FDA Commissioner Gottlieb Resigns - Washington Post, Citing Administration Official
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts MO Hot Sheet
Join SI Premium – FREE
(Updated - March 5, 2019 3:14 PM EST)
FDA Commissioner Scott Gottlieb resigned Tuesday, effective in about a month, according to the Washington Post, citing an administration official.
Tobacco names including Altria Group (NYSE: MO) climbed on the headline, while several biotech stocks including Vertex Pharma (NASDAQ: VRTX) declined.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA accepts Biohaven's troriluzole NDA resubmission for rare disease
- Celcuity reports Phase 1b/2 mCRPC trial data at ESMO 2026
- Takeda's TAK-921 meets dual endpoints in gastric cancer trial
Create E-mail Alert Related Categories
ETFs, FDA, Hot FDA News, Politics, Rumors, Trader TalkRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
